Nocturnal urinary continence is dependent on 3 factors: 1) nocturnal urine production, 2)
nocturnal bladder function and 3) sleep and arousal mechanisms. Any child will suffer from …

OBJECTIVE: To evaluate outcomes of desmopressin treatment in monosymptomatic
enuresis (ME) and nonmonosymptomatic enuresis (NME). MATERIALS AND METHODS …

Aim The aim of this study is to evaluate the use of desmopressin acetate (DDAVP) in the
management of nocturnal enuresis in patients with spinal cord injury (SCI), as well as …

Aims To systematically assess all available evidence on efficacy and safety of desmopressin
for treating nocturia in patients with multiple sclerosis (MS). Methods This systematic review …

Objectives: The objective of the study was to evaluate the safety and efficacy of high-
concentration intranasal desmopressin (HCIN-DDAVP) 1.5 mg/mL, in patients weighing≤ …

Objective The aim of the study is to evaluate the efficacy of desmopressin therapy in the
symptomatic treatment of nocturia in patients with multiple sclerosis (MS) and neurogenic …

This paper is a review of outcome definitions and criteria for nocturnal enuresis treatment. A
search of the literature published between 1991 and 2001 highlighted 97 papers. Although …

Zusammenfassung Fragestellung: Ziel der Arbeit ist die Analyse unterschiedlicher
Krankheitsmerkmale von Enuresis und kindlicher Harninkontinenz im Vergleich zweier …

Background: Disturbances of central regulatory processes of sleep and arousal are potential
causes of nocturnal enuresis. The intranasal application of an ADH analogue is an …

1.1 BACKGROUND At the end of the first year of life, retraction of the foreskin behind the
glandular sulcus is possible in only about 50% of boys; this rises to approximately 89% by …